Xiansheng Zeng
Xiangyang Key Laboratory Of Respiratory Health Research
Xiangyang, China
Xiangyang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
A Subgroup Reanalysis of the Efficacy of Bufei Huoxue Capsules in Patients With "Long-Covid-19".
Journal: Pulmonary circulation
Published: November 26, 2024
A deep insight into ferroptosis in lung disease: facts and perspectives.
Journal: Frontiers in oncology
Published: December 19, 2023
Prevalence and risk factors for postinfectious cough in discharged patients with coronavirus disease 2019 (COVID-19).
Journal: Journal of thoracic disease
Published: May 25, 2021
Efficacy and safety of Bufei Huoxue capsules in the management of convalescent patients with COVID-19 infection: A multicentre, double-blind, and randomised controlled trial.
Journal: Journal of ethnopharmacology
Published: April 20, 2021
Virtual Reality Exposure Therapy (VRET) for Anxiety Due to Fear of COVID-19 Infection: A Case Series.
Journal: Neuropsychiatric disease and treatment
Published: August 12, 2020
Short-term outcomes of COVID-19 and risk factors for progression.
Journal: The European respiratory journal
Published: March 06, 2020
Genetic Variants in the Hedgehog Interacting Protein Gene Are Associated with the FEV1/FVC Ratio in Southern Han Chinese Subjects with Chronic Obstructive Pulmonary Disease.
Journal: BioMed research international
Published: May 15, 2017
Two-stage study of lung cancer risk modification by a functional variant in the 3'-untranslated region of SMAD5 based on the bone morphogenetic protein pathway.
Journal: Molecular and clinical oncology
Published: September 01, 2016
Immunomodulation by mesenchymal stem cells in treating human autoimmune disease-associated lung fibrosis.
Journal: Stem cell research & therapy
Published: May 17, 2015
Last Updated: 09/26/2026